Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 5/20 | 1.00 |
| ▸ | IKBKB | O14920 | 5/20 | 1.00 |
| ▸ | PRKAG1 | P54619 | 5/20 | 1.00 |
| ▸ | PRKAA1 | Q13131 | 5/20 | 1.00 |
| ▸ | NEK1 | Q96PY6 | 5/20 | 1.00 |
| ▸ | PRKAB1 | Q9Y478 | 5/20 | 1.00 |
| ▸ | RAF1 | P04049 | 3/20 | 1.00 |
| ▸ | RPS6KB1 | P23443 | 3/20 | 1.00 |
| ▸ | AKT1 | P31749 | 3/20 | 1.00 |
| ▸ | AKT2 | P31751 | 3/20 | 1.00 |
| ▸ | KDR | P35968 | 3/20 | 1.00 |
| ▸ | MAPKAPK2 | P49137 | 3/20 | 1.00 |
| ▸ | MAP2K1 | Q02750 | 3/20 | 1.00 |
| ▸ | PRDX1 | Q06830 | 1/20 | 0.68 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 7/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.62 |
| ▸ | NPC1 | O15118 | 5/20 | 0.62 |
| ▸ | RAB9A | P51151 | 5/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10062873 | 1.00 | MAPK1 (1.00) | MAPK1IKBKBPRKAG1PRKAA1NEK1 | |
| SCHEMBL29794510 | 0.81 | IKBKB (1.00) | MAPK1IKBKBPRKAG1PRKAA1NEK1 | |
| SCHEMBL21460534 | 0.81 | IKBKB (1.00) | MAPK1IKBKBPRKAG1PRKAA1NEK1 | |
| SCHEMBL21460535 | 0.81 | IKBKB (1.00) | MAPK1IKBKBPRKAG1PRKAA1NEK1 | |
| SCHEMBL12948680 | 0.81 | MAPK1 (0.70) | MAPK1IKBKBPRKAG1PRKAA1NEK1 | |
| SCHEMBL8106620 | 0.81 | IKBKB (1.00) | MAPK1IKBKBPRKAG1PRKAA1NEK1 | |
| SCHEMBL17899536 | 0.79 | IKBKB (0.68) | MAPK1IKBKBPRKAG1PRKAA1NEK1 | |
| SCHEMBL17899485 | 0.77 | MAPT (1.00) | MAPK1IKBKBPRKAG1PRKAA1NEK1 | |
| SCHEMBL8120726 | 0.77 | IKBKB (1.00) | MAPK1IKBKBPRKAG1PRKAA1NEK1 | |
| SCHEMBL29437157 | 0.77 | IKBKB (1.00) | MAPK1IKBKBPRKAG1PRKAA1NEK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12602749-B2 | Parameter optimizing method of neural network and computing apparatus | GENESYS LOGIC, INC. (TW) | 2026-04-14 | — | — | US | disclosed |
| CN-118607578-A | Parameter optimization method and computing device of neural network | 创惟科技股份有限公司 | 2024-09-06 | — | — | CN | disclosed |
| US-20240296520-A1 | PARAMETER OPTIMIZING METHOD OF NEURAL NETWORK AND COMPUTING APPARATUS | GENESYS LOGIC, INC. (TW) | 2024-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12602749-B2 | Parameter optimizing method of neural network and computing apparatus | NCDN, CACNG2, CACNG6 | MAPK1 4038/4885IKBKB 1269/4885PRKAG1 1937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.